List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 5418 studies with search of:   Canada
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Natalizumab
2 Completed Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Adalimumab
3 Completed A New Oral Treatment For Type II Diabetes Mellitus
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: GW0823093
4 Completed Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
Condition: Osteoarthritis, Knee
Intervention: Drug: GW406381
5 Active, not recruiting Prospective Evaluation of Proteinuria and Renal Function in Non-Diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
6 Completed Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
Conditions: Dysmenorrhea;   Dyspareunia;   Endometriosis;   Pelvic Pain
Intervention: Drug: ERB-041
7 Completed Safety Study of Apixaban in Recent Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Interventions: Drug: Apixaban;   Drug: Apixaban;   Drug: Placebo
8 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
9 Recruiting Temozolomide and Everolimus in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: everolimus;   Drug: temozolomide;   Procedure: adjuvant therapy;   Procedure: gene expression profiling;   Procedure: immunohistochemistry staining method;   Procedure: pharmacological study
10 Active, not recruiting A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin
Conditions: Non-Insulin-Dependent Diabetes Mellitus;   Type 2 Diabetes Mellitus
Intervention: Drug: Rosiglitazone maleate/metformin hydrochloride (AVANDAMET)
11 Recruiting Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)
Condition: Hepatitis C, Chronic
Intervention: Drug: Combination of pegylated interferon alfa-2b and ribavirin
12 Completed Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: UK-432,097;   Drug: Placebo
13 Recruiting A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365;   Drug: Placebo
14 Completed Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.
Conditions: Pulmonary Disease, Chronic Obstructive;   Asthma
Intervention: Drug: BI 1744CL
15 Recruiting Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
Conditions: Coronary Artery Disease (CAD);   Percutaneous Coronary Intervention (PCI)
Interventions: Drug: M118;   Drug: Unfractionated Heparin
16 Recruiting Study Evaluating the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Menopausal Women
Condition: Vasomotor Symptoms
Interventions: Drug: desvenlafaxine succinate (DVS) SR;   Drug: Placebo
17 Active, not recruiting Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM1)
Condition: Hepatitis C, Chronic
Interventions: Drug: Boceprevir (SCH 503034);   Biological: Peginterferon alfa-2b (SCH 54031);   Drug: Ribavirin (SCH 18908);   Drug: Boceprevir placebo
18 Recruiting Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: alb-interferon alfa 2b;   Drug: alb-interferon alfa 2b;   Drug: alb-interferon alfa 2b;   Drug: alb-interferon alfa 2b;   Drug: peg-interferon
19 Recruiting Effects of Rosuvastatin on Aortic Stenosis Progression
Condition: Aortic Stenosis
Interventions: Drug: Rosuvastatin;   Drug: Placebo
20 Active, not recruiting Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: leucovorin calcium;   Procedure: observation

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services